by Ross Neitz, University of Alberta Faculty of Medicine & Dentistry An implantable device that monitors for atrial fibrillation over 12 months is more than three times more effective at detecting the condition than standard care, and could help prevent disabling strokes in patients, according to an Alberta clinical trial. Credit: University of Alberta Faculty of...
